PMVP
Price
$1.53
Change
+$0.05 (+3.38%)
Updated
Oct 4 closing price
32 days until earnings call
SLN
Price
$18.64
Change
-$0.63 (-3.27%)
Updated
Oct 4 closing price
Ad is loading...

PMVP vs SLN

Header iconPMVP vs SLN Comparison
Open Charts PMVP vs SLNBanner chart's image
PMV Pharmaceuticals
Price$1.53
Change+$0.05 (+3.38%)
Volume$267.85K
CapitalizationN/A
Silence Therapeutics
Price$18.64
Change-$0.63 (-3.27%)
Volume$144.07K
CapitalizationN/A
View a ticker or compare two or three
PMVP vs SLN Comparison Chart
Loading...
PMVP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
PMVP vs. SLN commentary
Oct 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMVP is a StrongBuy and SLN is a StrongBuy.

COMPARISON
Comparison
Oct 07, 2024
Stock price -- (PMVP: $1.53 vs. SLN: $18.64)
Brand notoriety: PMVP and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PMVP: 125% vs. SLN: 65%
Market capitalization -- PMVP: $76.76M vs. SLN: $806.56M
PMVP [@Biotechnology] is valued at $76.76M. SLN’s [@Biotechnology] market capitalization is $806.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PMVP’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 0 green FA rating(s).

  • PMVP’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 0 green, 5 red.
According to our system of comparison, both PMVP and SLN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PMVP’s TA Score shows that 4 TA indicator(s) are bullish while SLN’s TA Score has 5 bullish TA indicator(s).

  • PMVP’s TA Score: 4 bullish, 5 bearish.
  • SLN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SLN is a better buy in the short-term than PMVP.

Price Growth

PMVP (@Biotechnology) experienced а +2.00% price change this week, while SLN (@Biotechnology) price change was +2.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was -5.77%.

Reported Earning Dates

PMVP is expected to report earnings on Nov 07, 2024.

SLN is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLN($807M) has a higher market cap than PMVP($76.8M). SLN YTD gains are higher at: 7.311 vs. PMVP (-50.645). SLN has higher annual earnings (EBITDA): -47.64M vs. PMVP (-75.47M). PMVP has more cash in the bank: 213M vs. SLN (150M). SLN has less debt than PMVP: SLN (184K) vs PMVP (13M). SLN has higher revenues than PMVP: SLN (17.9M) vs PMVP (0).
PMVPSLNPMVP / SLN
Capitalization76.8M807M10%
EBITDA-75.47M-47.64M158%
Gain YTD-50.6457.311-693%
P/E RatioN/AN/A-
Revenue017.9M-
Total Cash213M150M142%
Total Debt13M184K7,065%
TECHNICAL ANALYSIS
Technical Analysis
PMVPSLN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 18 days ago
78%
Bullish Trend 4 days ago
90%
Declines
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 11 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
76%
View a ticker or compare two or three
Ad is loading...
PMVP
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLX1.080.07
+6.93%
Protalix BioTherapeutics
THRM42.650.51
+1.21%
Gentherm
TX36.860.26
+0.71%
Ternium SA
AURA8.72-0.01
-0.11%
Aura Biosciences
KO70.17-0.35
-0.50%
Coca-Cola Company

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with MDGL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
+3.38%
MDGL - PMVP
44%
Loosely correlated
+0.89%
ARVN - PMVP
34%
Loosely correlated
+1.96%
CARM - PMVP
33%
Loosely correlated
+1.61%
RPTX - PMVP
33%
Loosely correlated
+8.38%
ORMP - PMVP
33%
Loosely correlated
-2.49%
More